Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02177695
Title S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Southwest Oncology Group
Indications

urinary bladder cancer

Therapies

Cisplatin + Gemcitabine

Aldoxorubicin + Cisplatin + Filgrastim + Methotrexate + Vinblastine

Age Groups: adult
Covered Countries USA


No variant requirements are available.